2nd round of COVID-19 Sero-prevalence study begins in Delhi


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ 2nd-round-covid19-seroprevalence-study-conducted-delhi-different-areas-next-five-days
This second round survey is being conducted in the different areas of the city in the next five days

The sero-prevalence study began today in Delhi. This second round survey is being conducted in the different areas of the city in the next five days.

The first phase of the study was conducted from the 27th of June to the 10th of July in all the 11 districts of Delhi. During the survey, a total of 21,387 blood samples were collected from selected individuals and were tested for IgG antibodies using the ELISA testing kits.

The study showed that only 22.86% of the people are affected due to Coronavirus and 77% population is still vulnerable. The study also indicated that a large number of infected persons remain asymptomatic. The tests have been done to identify the presence of antibodies in the general population. It provided information about past COVID-19 infection in individuals who tested positive.

The report says that antibody testing like Sero study provides important evidence for assessing the spread of the pandemic. Depending upon the level of sero-prevalence of infection, appropriate public health interventions can be planned and implemented for prevention and control of the disease. As per the Indian Council of Medical Research, periodic sero-surveys are useful to guide the policymakers to conduct surveys in high-risk areas or vulnerable population who have been infected in the past and has now recovered.

Meanwhile, A total of 1118 new confirmed cases of Coronavirus were reported in Delhi during the last twenty-four hours taking the total number of cases to 1,36,716. Delhi Government has confirmed that over 1,22,000 people affected with Coronavirus have been cured so far.

In the last 24 hours, 1,201 people recovered and 26 deaths were reported in the National Capital taking the toll to 3,989. Presently, the total number of active cases in the national capital is 10,596.

In the other news update, Bihar Chief Minister Nitish Kumar instructed to further increase the number of Covid-19 tests in all the districts and start rapid antigen tests of people taking shelter in flood relief camps.

Mr. Kumar said those keen to get themselves tested for COVID 19 should not face hassles. He instructed to provide medicine kits to those in home isolation and taking feedback from all positive patients daily via phone call. The Chief Minister asked the health department to equip ICUs of all hospitals with ventilators.

Meanwhile, positive cases in Bihar have mounted to 50,987 with 2,986 fresh cases. This is the single-day highest spike in positive cases in the state. 33,650 patients were recovered and 17038 patients are undergoing treatment in various hospitals. 298 people died so far.  It was reported that the Corona Recovery rate is 66%.

Testing capacity has been increased to over 20000 per day. Altogether 5,48,000 tests have been conducted so far across the state.

Tags : #Delhi #ELISAtestingkits #ICMR #CMNitishKumar

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026